• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有镰状细胞病的儿童因2019冠状病毒病肺炎和急性胸综合征入住儿科重症监护病房:病例报告。

A child with sickle cell disease admitted with coronavirus disease 2019 pneumonia and acute chest syndrome in pediatric intensive care unit: A case report.

作者信息

Raza Mohammad, Alshehri Saleh Saad, Pasha Mohsina Reshma

机构信息

Pediatric Intensive Care Unit, Tawam Hospital, Al Ain, UAE.

Pediatric Intensive Care Unit, King Saud Medical City, Riyadh, Saudi Arabia.

出版信息

SAGE Open Med Case Rep. 2024 Jul 26;12:2050313X241266436. doi: 10.1177/2050313X241266436. eCollection 2024.

DOI:10.1177/2050313X241266436
PMID:39071200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11282508/
Abstract

Management of sickle cell disease complications in the setting of the coronavirus disease 2019 (COVID-19) pandemic is complicated with little published pediatric data. We report the first documented case of a 9-year-old boy with sickle cell disease, presenting with fever, cough, and shortness of breath, diagnosed to have acute chest syndrome and coronavirus disease 2019 (COVID-19) pneumonia with inflammatory storm requiring ventilation, exchange blood transfusion, immunomodulatory agents, and prophylactic anticoagulation. The patient responded satisfactorily to the management of the acute illness and was found to be well at the next visit to the pediatric hematology outpatient department following hospital discharge.

摘要

在2019冠状病毒病(COVID-19)大流行背景下,镰状细胞病并发症的管理很复杂,且几乎没有已发表的儿科数据。我们报告了首例有记录的9岁镰状细胞病男孩病例,该男孩出现发热、咳嗽和呼吸急促,被诊断为急性胸综合征以及伴有炎症风暴的2019冠状病毒病(COVID-19)肺炎,需要通气、换血输血、免疫调节药物和预防性抗凝治疗。患者对急性疾病的治疗反应良好,出院后在下次儿科血液科门诊就诊时情况良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099f/11282508/e75413c8b40c/10.1177_2050313X241266436-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099f/11282508/0ef7e33a76d8/10.1177_2050313X241266436-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099f/11282508/8601191eb133/10.1177_2050313X241266436-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099f/11282508/bfc86c493f5e/10.1177_2050313X241266436-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099f/11282508/e75413c8b40c/10.1177_2050313X241266436-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099f/11282508/0ef7e33a76d8/10.1177_2050313X241266436-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099f/11282508/8601191eb133/10.1177_2050313X241266436-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099f/11282508/bfc86c493f5e/10.1177_2050313X241266436-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099f/11282508/e75413c8b40c/10.1177_2050313X241266436-fig4.jpg

相似文献

1
A child with sickle cell disease admitted with coronavirus disease 2019 pneumonia and acute chest syndrome in pediatric intensive care unit: A case report.一名患有镰状细胞病的儿童因2019冠状病毒病肺炎和急性胸综合征入住儿科重症监护病房:病例报告。
SAGE Open Med Case Rep. 2024 Jul 26;12:2050313X241266436. doi: 10.1177/2050313X241266436. eCollection 2024.
2
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.随机对照试验比较高剂量与低剂量低分子肝素在需要侵入性机械通气的严重 COVID-19 肺炎和凝血病住院患者中的疗效和安全性 (COVID-19 HD):研究方案的结构化总结。
Trials. 2020 Jun 26;21(1):574. doi: 10.1186/s13063-020-04475-z.
3
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.多中心、三臂、随机对照试验研究甲泼尼龙和普通肝素在 SARS-CoV-2 感染肺炎危重症机械通气患者中的应用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Aug 17;21(1):724. doi: 10.1186/s13063-020-04645-z.
4
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.住院 COVID-19 患者的凝血病:治疗性抗凝与标准治疗作为对 COVID-19 大流行的快速反应的实用随机对照试验 (RAPID COVID COAG - RAPID 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
5
Sickle Cell Disease and COVID-19 Infection: Importance of COVID-19 Testing and Approach to Management.镰状细胞病与新型冠状病毒肺炎感染:新型冠状病毒肺炎检测的重要性及管理方法
Cureus. 2022 Mar 29;14(3):e23604. doi: 10.7759/cureus.23604. eCollection 2022 Mar.
6
A child infected with severe acute respiratory syndrome coronavirus 2 presenting with diarrhea without fever and cough: A case report.一名感染严重急性呼吸综合征冠状病毒2且无发热和咳嗽症状仅表现为腹泻的儿童:病例报告。
Medicine (Baltimore). 2020 Aug 14;99(33):e21427. doi: 10.1097/MD.0000000000021427.
7
SARS CoV-2 infection in a patient with sickle cell disease - Atypical presentation.一名镰状细胞病患者感染新型冠状病毒2 - 非典型表现
J Family Med Prim Care. 2021 Apr;10(4):1792-1794. doi: 10.4103/jfmpc.jfmpc_2210_20. Epub 2021 Apr 29.
8
Early Noninvasive Ventilation and Nonroutine Transfusion for Acute Chest Syndrome in Sickle Cell Disease in Children: A Descriptive Study.儿童镰状细胞病急性胸部综合征的早期无创通气和非常规输血:描述性研究。
Pediatr Crit Care Med. 2018 May;19(5):e235-e241. doi: 10.1097/PCC.0000000000001468.
9
Children in Critical Care Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Experience in a Spanish Hospital.因严重急性呼吸综合征冠状病毒 2 感染而入住重症监护病房的儿童:一家西班牙医院的经验。
Pediatr Crit Care Med. 2020 Aug;21(8):e576-e580. doi: 10.1097/PCC.0000000000002475.
10
Deep venous thrombosis and acute pericarditis associated with severe acute respiratory syndrome coronavirus 2 infection in a Congolese infant with sickle cell disease: a case report.刚果一名镰状细胞病婴儿感染严重急性呼吸综合征冠状病毒 2 后并发深静脉血栓形成和急性心包炎:病例报告。
J Med Case Rep. 2022 Aug 10;16(1):307. doi: 10.1186/s13256-022-03459-8.

引用本文的文献

1
New frontiers in sickle cell disease: The role of antiviral therapies and emerging drugs in managing viral infections.镰状细胞病的新前沿:抗病毒疗法和新兴药物在管理病毒感染中的作用。
World J Virol. 2025 Jun 25;14(2):101693. doi: 10.5501/wjv.v14.i2.101693.

本文引用的文献

1
Thromboprophylaxis for Coagulopathy Related to COVID-19 in Pediatrics: A Narrative Review.儿童 COVID-19 相关凝血功能障碍的血栓预防:叙事性综述。
Paediatr Drugs. 2023 Jul;25(4):443-452. doi: 10.1007/s40272-023-00566-x. Epub 2023 May 4.
2
The impact of COVID-19 in children with Sickle Cell Disease: Results of a multicentric registry.COVID-19 对镰状细胞病儿童的影响:一项多中心登记研究的结果。
PLoS One. 2023 Apr 6;18(4):e0282423. doi: 10.1371/journal.pone.0282423. eCollection 2023.
3
Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospital.
镰状细胞病儿童和青少年感染新冠病毒的临床结局:一家大都市三级儿科医院的年度回顾
Front Med (Lausanne). 2023 Feb 17;10:987194. doi: 10.3389/fmed.2023.987194. eCollection 2023.
4
Multisystem Inflammatory Syndrome in a Previously Vaccinated Adolescent Female With Sickle Cell Disease.镰状细胞病既往接种疫苗的少女发生多系统炎症综合征
Pediatr Infect Dis J. 2022 Mar 1;41(3):e104-e105. doi: 10.1097/INF.0000000000003444.
5
COVID-19 in Saudi Patients With Sickle Cell Disease: A Retrospective Multi-Center Study.沙特镰状细胞病患者中的新型冠状病毒肺炎:一项回顾性多中心研究。
Cureus. 2021 Aug 16;13(8):e17238. doi: 10.7759/cureus.17238. eCollection 2021 Aug.
6
Multisystem Inflammatory Syndrome in a Pediatric Patient With Sickle Cell Disease and COVID-19: A Case Report.儿童镰状细胞病合并 COVID-19 患者的多系统炎症综合征:病例报告。
J Pediatr Hematol Oncol. 2022 Jan 1;44(1):e134-e137. doi: 10.1097/MPH.0000000000002191.
7
Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents.儿童严重 COVID-19:抗风湿药物作用的最新进展。
Pediatr Rheumatol Online J. 2021 May 4;19(1):68. doi: 10.1186/s12969-021-00559-5.
8
Acute chest syndrome and COVID-19 in sickle cell disease pediatric patients.镰状细胞病儿科患者的急性胸部综合征与新型冠状病毒肺炎
Hematol Transfus Cell Ther. 2021 Jan-Mar;43(1):104-108. doi: 10.1016/j.htct.2020.11.005. Epub 2020 Dec 19.
9
Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia.羟氯喹在沙特阿拉伯 COVID-19 门诊患者批准治疗方案内的安全性结果。
Int J Infect Dis. 2021 Jan;102:110-114. doi: 10.1016/j.ijid.2020.10.031. Epub 2020 Oct 17.
10
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis.氯喹或羟氯喹治疗 COVID-19 患者的疗效:系统评价和荟萃分析。
J Antimicrob Chemother. 2021 Jan 1;76(1):30-42. doi: 10.1093/jac/dkaa403.